Company intelligence
OGT
What binds us, makes us.
Biotechnology
Kidlington, GB
51–200 employees
Founded 1995
3 public signals
About OGT
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, arrays and FISH reflects our commitment to improving the future of genetic clinical care. We offer partnership and collaboration to our customers at every stage of their work.
Verified activity
Signals from OGT
3 published signals
Presence & Recognition
OGT shared a post from its parent company, Sysmex, on World Leukaemia Day.
Reported by OGT
Legal & Regulatory
OGT is committed to transitioning the full CytoCell IVDD portfolio to IVDR by the 31 December 2028 deadline alongside a broad range of non-IVDD probes such as existing custom myProbes.
Reported by OGT
Presence & Recognition
OGT is attending The Foundation for Genetic Technology Southeast Regional Genetics Meeting 2026.
Reported by OGT